Walter K. Kraft
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Doravirine, Rifapentine and Isoniazid Interaction (NCT03886701) | Walter K. Kraft | 2019-04-22 |
Track Walter K. Kraft automatically
Every clearance here is in the API, with alerts when new ones post.